BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30258795)

  • 1. A Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Center in Punjab.
    Jha N; Alexander E; Kanish B; Badyal DK
    Indian Dermatol Online J; 2018; 9(5):299-303. PubMed ID: 30258795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Cutaneous Adverse Drug Reactions (ADR) Reported at an ADR Monitoring Center of a Tertiary Care Teaching Institute in Central India.
    Chindhalore CA; Gupta AV; Dakhale GN; Srivastava A
    Cureus; 2024 Feb; 16(2):e53706. PubMed ID: 38455795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous adverse drug reactions in Indian population: A systematic review.
    Patel TK; Thakkar SH; Sharma D
    Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S76-86. PubMed ID: 25593813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.
    Ashifha S; Vijayashree J; Vudayana K; Chintada D; P P; G P; Unnikrishnan P
    Cureus; 2023 Apr; 15(4):e37596. PubMed ID: 37197134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nevirapine: Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care Hospital.
    Pawar MP; Pore SM; Pradhan SN; Burute SR; Bhoi UY; Ramanand SJ
    J Clin Diagn Res; 2015 Nov; 9(11):FC17-20. PubMed ID: 26672558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological study of cutaneous adverse drug reactions in oman.
    Al-Raaie F; Banodkar DD
    Oman Med J; 2008 Jan; 23(1):21-7. PubMed ID: 22567204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
    Choon SE; Lai NM
    Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of cutaneous adverse drug reactions.
    Mockenhaupt M
    Allergol Select; 2017; 1(1):96-108. PubMed ID: 30402608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological Pattern of Cutaneous Adverse Drug Reactions due to Antiepileptic Drugs in Eastern India.
    Singh PK; Kumar MK; Kumar D; Kumar P
    J Clin Diagn Res; 2015 Jan; 9(1):WC01-3. PubMed ID: 25738068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in culprit drugs and clinical entities in cutaneous adverse drug reactions: a retrospective study.
    Wang F; Zhao YK; Li M; Zhu Z; Zhang X
    Cutan Ocul Toxicol; 2017 Dec; 36(4):370-376. PubMed ID: 28423957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous cutaneous adverse drug reaction reports-An analysis of a 10-year dataset in Singapore.
    Wong SX; Tham MY; Goh CL; Cheong HH; Chan SY
    Pharmacol Res Perspect; 2019 Apr; 7(2):e00469. PubMed ID: 30911397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of cutaneous adverse drug reactions.
    Mockenhaupt M
    Chem Immunol Allergy; 2012; 97():1-17. PubMed ID: 22613850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Clinico-Epidemiological Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Centre of Eastern India.
    Sinha S; Kar C; Das S; Dutta A; De A
    Indian J Dermatol; 2024; 69(1):106. PubMed ID: 38572036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe cutaneous adverse reactions in a tertiary care center in Jamaica.
    McNish AJS; Ho JD; East-Innis ADC
    JAAD Int; 2024 Jun; 15():139-146. PubMed ID: 38545494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agreement Among Different Scales for Causality Assessment in Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Sivagourounadin K; Rajendran P; Selvarajan S; Ganesapandian M
    Curr Drug Saf; 2022; 17(1):40-46. PubMed ID: 34126908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
    Ding WY; Lee CK; Choon SE
    Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study.
    Thakkar S; Patel TK; Vahora R; Bhabhor P; Patel R
    Indian J Dermatol; 2017; 62(6):618-625. PubMed ID: 29263536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse cutaneous drug reactions: Eight year assessment in hospitalized patients.
    Mokhtari F; Nikyar Z; Naeini BA; Esfahani AA; Rahmani S
    J Res Med Sci; 2014 Aug; 19(8):720-5. PubMed ID: 25422656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous adverse drug reaction profile in a tertiary care out patient setting in eastern India.
    Saha A; Das NK; Hazra A; Gharami RC; Chowdhury SN; Datta PK
    Indian J Pharmacol; 2012; 44(6):792-7. PubMed ID: 23248414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermoscopic Aspects of Cutaneous Adverse Drug Reactions.
    Rossi G; da Silva Cartell A; Marchiori Bakos R
    Dermatol Pract Concept; 2021 Jan; 11(1):e2021136. PubMed ID: 33614215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.